Assignee
APTABIO THERAPEUTICS INC
KR·4 granted patents·5 pending applications·5 citations·filing 2018–2025
Top patents by PatentIndex Score
9 records- 0185US11174240B2Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochlorideAPTABIO THERAPEUTICS INC·Filed 2018·Granted Nov 16, 2021·3 cites·9 claims
- 0284US10966969B2Therapeutic agent for liver diseasesAPTABIO THERAPEUTICS INC·Filed 2018·Granted Apr 6, 2021·2 cites·11 claims
- 0366US2024308983A1Novel pyrazole derivativesAPTABIO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0465US2025304612A1Therapeutic agent for blood cancerAPTABIO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0562US11999718B2Pyrazole derivativesAPTABIO THERAPEUTICS INC·Filed 2023·Granted Jun 4, 2024·0 cites·12 claims
- 0653US2023201179A1Agent for treating contrast-induced acute kidney injuryAPTABIO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0750US2023192752A1Therapeutic agent for blood cancerAPTABIO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 0848US12509438B2Pyrazole derivativeAPTABIO THERAPEUTICS INC·Filed 2021·Granted Dec 30, 2025·0 cites·10 claims
- 0948US2023148365A1Pulmonary fibrosis medicine containing pyrazole derivativeAPTABIO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →